Article Data

  • Views 370
  • Dowloads 104

Case Reports

Open Access

Leiomyosarcoma after hysteroscopic myomectomy: a case report

  • G. Carta1,*,
  • P. Palermo1
  • R. Di Ramio1
  • V. De Lellis1
  • A. Carta1
  • F. Patacchiola1

1Department of Surgical Sciences, University of L’Aquila, Italy

DOI: 10.12892/ejgo201206656 Vol.33,Issue 6,November 2012 pp.656-657

Published: 10 November 2012

*Corresponding Author(s): G. Carta E-mail: gaspare.carta@cc.univaq.it/ gasparecarta@libero.it

Abstract

Objectives: The aim of this study was to illustrate the importance of hysteroscopy in the evolution of mitotically active leiomyoma to leiomyosarcoma (LMS). Uterine sarcomas are rare tumors. The three microscopic criteria are: 1) the presence of coagulative tumor necrosis, 2) high mitotic index (exceeding 15 x 10 catabolite gene activator (CGA) and 3) occurrence of moderate to severe cytologic atypia. The authors report a case of a 52-year-old nulliparous woman with a LMS detected two months after a hysteroscopic resection of a mitotically active leiomyoma. After the first hysteroscopic resection the diagnosis was atypical leiomyoma with a mitotic index of two per ten high-power field (hpf) in the absence of coagulation necrosis. After two months, a new myoma was detected and another hysteroscopic resection was performed: the microscopic diagnosis was LMS and a total abdominal hysterectomy with bilateral salpingo-oophorectomy (BSO) was performed. Conclusion: The patient must undergo close clinical and instrumental follow-up procedures. Hysteroscopy plays an important role in the evaluation and evolution of both recurrent and de novo disease.

Keywords

Leiomyosarcoma; Hysteroscopy

Cite and Share

G. Carta,P. Palermo,R. Di Ramio,V. De Lellis,A. Carta,F. Patacchiola. Leiomyosarcoma after hysteroscopic myomectomy: a case report. European Journal of Gynaecological Oncology. 2012. 33(6);656-657.

References

[1] Ueda S.M., Kapp D.S., Cheung M.K., Shin J.Y., Osann K., Husain A. et al.: “Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths”. Am. J. Obstet. Gynecol., 2008, 198, 218.

[2] Wang W.L. et al.: “Histopathologic prognostic factors in Stage I leiomyosarcoma of the uterus: a detailed analysis of 27 cases”. Am. J. Surg. Pathol., 2011, 35, 522.

[3] Tavassoli F.A., Devilee P.: “Tumors of the breast and female genital organs”. World Health Organization Classification of Tumours. International Agency for Research on Cancer (IARC), IARC Press, Lyon, 2003.

[4] Kempson R.L., Hendrickson M.R.: “Smooth muscle, endometrial stromal and mixed Müllerian tunors of the uterus”. Mod. Pathol., 2000, 13, 328.

[5] Bansal N., Herzong T.J., Brunner-Brown A., Wethington S.L., Cohen C.J., Burke W.M., Wright J.D.: “The utility of preoperative endometrial sampling for the detection of uterine sarcomas”. Gynecol. Oncol., 2008, 110, 43.

[6] Prat J.: “FIGO staging for uterine sarcomas”. Int. J. Gynecol. Obstet., 2009, 104, 177.

[7] Gadducci A., Cosio S., Romanini A., Gennazzani A.R.: “The management of patients with uterine sarcoma: a debated clinicl challenge”. Crit. Rew. Oncol. Hematol., 2008, 65, 129.

[8] Kim J.H., Choi Y.J., Kim D.C., Lee S.J.: “Leiomyosarcoma arising in a patient with prior mitotically active leiomyoma”. J. Obstet. Gynaecol. Res., 2010, 36, 187.

[9] Giuntoli R.L. 2nd: “Secondary cytoreduction in the management of recurrent uterine leiomyosarcoma”. Gynecol. Oncol., 2007, 106, 82.

[10] Kapp D.S., Shin J.Y., Chan J.K.: “Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomy”. Cancer, 2008, 112, 820.

[11] Seddon M.S., Davda R.: “Uterine sarcomas - Recent progress and future challenges”. Eur. J. Radiol., 2011, 78, 30.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top